Berit Rosche

1.1k total citations
23 papers, 890 citations indexed

About

Berit Rosche is a scholar working on Pathology and Forensic Medicine, Immunology and Rheumatology. According to data from OpenAlex, Berit Rosche has authored 23 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 8 papers in Immunology and 6 papers in Rheumatology. Recurrent topics in Berit Rosche's work include Multiple Sclerosis Research Studies (13 papers), Immunotherapy and Immune Responses (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Berit Rosche is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Immunotherapy and Immune Responses (4 papers) and Systemic Lupus Erythematosus Research (4 papers). Berit Rosche collaborates with scholars based in Germany and United States. Berit Rosche's co-authors include Bernhard Hemmer, Norbert Sommer, Sabine Cepok, Verena Grummel, Friederike Vogel, Dun Zhou, Lutz Harms, Friedemann Paul, Hans‐Peter Hartung and Harald Prüß and has published in prestigious journals such as PLoS ONE, Brain and Epilepsia.

In The Last Decade

Berit Rosche

23 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berit Rosche Germany 14 403 275 158 151 141 23 890
Laura Adalid‐Peralta Mexico 18 196 0.5× 214 0.8× 128 0.8× 172 1.1× 126 0.9× 43 806
Bernhard Greve Germany 21 167 0.4× 734 2.7× 208 1.3× 135 0.9× 185 1.3× 34 1.6k
Mauri Reunanen Finland 18 294 0.7× 218 0.8× 150 0.9× 36 0.2× 143 1.0× 59 970
Vera Lehmensiek Germany 15 251 0.6× 227 0.8× 269 1.7× 29 0.2× 212 1.5× 22 848
Åslaug Rudjord Lorentzen Norway 16 203 0.5× 227 0.8× 127 0.8× 150 1.0× 83 0.6× 41 688
Nancy P. Robertson United States 14 279 0.7× 146 0.5× 153 1.0× 53 0.4× 247 1.8× 28 793
Federica Delunardo Italy 23 684 1.7× 256 0.9× 53 0.3× 483 3.2× 216 1.5× 35 1.4k
Gloria von Geldern United States 13 304 0.8× 124 0.5× 214 1.4× 26 0.2× 296 2.1× 32 994
A.J. Suckling United Kingdom 14 163 0.4× 333 1.2× 61 0.4× 52 0.3× 204 1.4× 41 824
Peter van der Meide Netherlands 21 86 0.2× 635 2.3× 289 1.8× 108 0.7× 274 1.9× 30 1.5k

Countries citing papers authored by Berit Rosche

Since Specialization
Citations

This map shows the geographic impact of Berit Rosche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berit Rosche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berit Rosche more than expected).

Fields of papers citing papers by Berit Rosche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berit Rosche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berit Rosche. The network helps show where Berit Rosche may publish in the future.

Co-authorship network of co-authors of Berit Rosche

This figure shows the co-authorship network connecting the top 25 collaborators of Berit Rosche. A scholar is included among the top collaborators of Berit Rosche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berit Rosche. Berit Rosche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdur, Hebun, Mathias Streitz, Markus Hammer, et al.. (2016). EBNA1 antigen-specific CD8 + T cells in cerebrospinal fluid of patients with multiple sclerosis. Journal of Neuroimmunology. 294. 14–17. 5 indexed citations
2.
Stascheit, Frauke, Friedemann Paul, Lutz Harms, & Berit Rosche. (2015). Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis. Journal of Neuroimmunology. 285. 119–124. 27 indexed citations
3.
Stascheit, Frauke, Friedemann Paul, Ulrike Grittner, Lutz Harms, & Berit Rosche. (2015). Toxoplasma gondii Seropositivity Is Negatively Associated With Multiple Sclerosis (P1.121). 84. 1 indexed citations
4.
Ruprecht, Klemens, Benjamin Wunderlich, René M. Gieß, et al.. (2014). Multiple sclerosis: The elevated antibody response to Epstein–Barr virus primarily targets, but is not confined to, the glycine–alanine repeat of Epstein–Barr nuclear antigen-1. Journal of Neuroimmunology. 272(1-2). 56–61. 35 indexed citations
5.
Fleischmann, Robert, Harald Prüß, Berit Rosche, et al.. (2014). Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of theN-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis. JAMA Neurology. 72(1). 96–96. 27 indexed citations
6.
7.
Prüß, Harald, Berit Rosche, Aaron B. Sullivan, et al.. (2013). Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial. PLoS ONE. 8(2). e55859–e55859. 83 indexed citations
9.
Rosche, Berit, et al.. (2012). Measles IgG Antibody Index Correlates with T2 Lesion Load on MRI in Patients with Early Multiple Sclerosis. PLoS ONE. 7(1). e28094–e28094. 26 indexed citations
10.
Malzahn, Uwe, Friedemann Paul, Eike Jakob Spruth, et al.. (2011). Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurology. 11(1). 123–123. 31 indexed citations
11.
Erdur, Hebun, Siegfried Köhler, Marco Frentsch, et al.. (2011). Immune monitoring ofTrichuris suisegg therapy in multiple sclerosis patients. Journal of Helminthology. 86(3). 339–347. 53 indexed citations
12.
Rosche, Berit, et al.. (2007). Stellenwert der Uveitis im Rahmen demyelinisierender Erkrankungen des Zentralnervensystems. Der Nervenarzt. 78(12). 1389–1398. 5 indexed citations
13.
Cepok, Sabine, Berit Rosche, Verena Grummel, et al.. (2005). Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain. 128(7). 1667–1676. 285 indexed citations
14.
Cepok, Sabine, Frederick Vogel, Verena Grummel, et al.. (2005). Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Aktuelle Neurologie. 32(S 4). 8 indexed citations
15.
Rosche, Berit, Marc Jacobsen, Sabine Cepok, et al.. (2004). Myositis in a patient with large granular leukocyte leukemia. Muscle & Nerve. 29(6). 873–877. 6 indexed citations
16.
Rosche, Berit, Sabine Cepok, Susanne Stei, et al.. (2004). The role of the Polio Virus Receptor and the Herpesvirus entry mediator B genes for the development of MS. Journal of Neuroimmunology. 156(1-2). 171–177. 9 indexed citations
17.
Kroner, Antje, Christoph Kleinschnitz, Bernhard Hemmer, et al.. (2004). Analysis of the monocyte chemoattractant protein 1 −2518 promoter polymorphism in patients with multiple sclerosis. Tissue Antigens. 64(1). 70–73. 11 indexed citations
18.
Rosche, Berit, B. C. Kieseier, H.‐P. Hartung, & Bernhard Hemmer. (2003). Neue Einblicke in die Immunpathogenese der Multiplen Sklerose. Der Nervenarzt. 74(8). 654–663. 1 indexed citations
19.
Cepok, Sabine, Dun Zhou, Friederike Vogel, et al.. (2003). The Immune Response at Onset and During Recovery From Borrelia burgdorferi Meningoradiculitis. Archives of Neurology. 60(6). 849–849. 60 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026